Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
18F-FDG PET in malignant lymphoma: significance of positive findings.
Castellucci P, Zinzani P, Pourdehnad M, Alinari L, Nanni C, Farsad M, Battista G, Tani M, Stefoni V, Canini R, Monetti N, Rubello D, Alavi A, Franchi R, Fanti S. Castellucci P, et al. Among authors: stefoni v. Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):749-56. doi: 10.1007/s00259-004-1748-x. Epub 2005 Mar 23. Eur J Nucl Med Mol Imaging. 2005. PMID: 15785956
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
Mauro FR, Zinzani P, Zaja F, Gentile M, Vegna ML, Stefoni V, Marin L, Fanin R, Baccarani M, Tura S, Mandelli F. Mauro FR, et al. Among authors: stefoni v. Haematologica. 2003 Dec;88(12):1348-57. Haematologica. 2003. PMID: 14687987 Clinical Trial.
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study.
Chiappella A, Dodero A, Evangelista A, Re A, Orsucci L, Usai SV, Castellino C, Stefoni V, Pinto A, Zanni M, Ciancia R, Ghiggi C, Rossi FG, Arcari A, Ilariucci F, Zilioli VR, Flenghi L, Celli M, Volpetti S, Benedetti F, Ballerini F, Musuraca G, Bruna R, Patti C, Leonardi F, Arcaini L, Magagnoli M, Cavallo F, Bermema A, Tucci A, Boccomini C, Ciccone G, Carniti C, Pileri SA, Corradini P. Chiappella A, et al. Among authors: stefoni v. Leukemia. 2023 Feb;37(2):433-440. doi: 10.1038/s41375-022-01780-1. Epub 2023 Jan 18. Leukemia. 2023. PMID: 36653509 Free PMC article. Clinical Trial.
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study.
Ferrero S, Rossi D, Rinaldi A, Bruscaggin A, Spina V, Eskelund CW, Evangelista A, Moia R, Kwee I, Dahl C, Di Rocco A, Stefoni V, Diop F, Favini C, Ghione P, Mahmoud AM, Schipani M, Kolstad A, Barbero D, Novero D, Paulli M, Zamò A, Jerkeman M, da Silva MG, Santoro A, Molinari A, Ferreri A, Grønbæk K, Piccin A, Cortelazzo S, Bertoni F, Ladetto M, Gaidano G. Ferrero S, et al. Among authors: stefoni v. Haematologica. 2020 Jun;105(6):1604-1612. doi: 10.3324/haematol.2018.214056. Epub 2019 Sep 19. Haematologica. 2020. PMID: 31537689 Free PMC article. Clinical Trial.
Bilateral primary breast lymphoma: a case of local recurrence.
Zinzani PL, Alinari L, Stefoni V, Tani M, Baccarani M. Zinzani PL, et al. Among authors: stefoni v. Leuk Lymphoma. 2003 Apr;44(4):737-8. doi: 10.1080/1042819031000067963. Leuk Lymphoma. 2003. PMID: 12769356 No abstract available.
146 results